An EGFR-Amplified Cervical Squamous Cell Carcinoma Patient with Pulmonary Metastasis Benefits from Afatinib: A Case Report

Currently, women with metastatic or recurrent cervical cancer still have very limited treatment options. Despite the rapid advancements in targeted therapies, no targeted therapy was approved for cervical cancer, except for bevacizumab. In the present study, we reported a 52-year-old heavily pre-tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Qian, Huang, Yihua, Shao, Lin, Han-Zhang, Han, Yang, Fan, Wang, Yang, Liu, Jing, Gan, Jiadi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7053816/
https://www.ncbi.nlm.nih.gov/pubmed/32184619
http://dx.doi.org/10.2147/OTT.S236382

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7053816/
https://www.ncbi.nlm.nih.gov/pubmed/32184619
http://dx.doi.org/10.2147/OTT.S236382

Ejemplares similares